Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1993;72:696-700

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muller, F. U.
Right arrow Articles by Scholz, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muller, F. U.
Right arrow Articles by Scholz, H.

Circulation Research, Vol 72, 696-700, Copyright © 1993 by American Heart Association


ARTICLES

Isoprenaline stimulates gene transcription of the inhibitory G protein alpha-subunit Gi alpha-2 in rat heart

FU Muller, KR Boheler, T Eschenhagen, W Schmitz and H Scholz
Abteilung Allgemeine Pharmakologie, Universitats-Krankenhaus Eppendorf, Universitat Hamburg, FRG.

In vitro transcription reactions were performed with isolated ventricular nuclei of adult rats to investigate whether increased mRNA levels of the inhibitory G protein alpha-subunit Gi alpha-2 after prolonged in vivo stimulation with the beta-adrenoceptor agonist isoprenaline are caused by increased transcription. Rats were treated by a 4-day subcutaneous infusion of isoprenaline (2.4 mg/kg per day) or 0.9% NaCl as control. To avoid the influence of developmental expression patterns, adult rats were chosen for all experiments. Signals for Gi alpha-2 and the stimulatory G protein alpha-subunit Gs alpha were specific and due to hybridization of nascent mRNA transcripts. In the isoprenaline group the transcriptional activity of Gi alpha-2 gene increased to 140% of the control value, whereas gene specific hybridization for Gs alpha remained unchanged. These results show that increased Gi alpha-2 mRNA levels after stimulation with isoprenaline are at least partially caused by enhanced transcription of Gi alpha-2 mRNA.


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. A Movsesian
Altered cAMP-mediated signalling and its role in the pathogenesis of dilated cardiomyopathy
Cardiovasc Res, June 1, 2004; 62(3): 450 - 459.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. U Muller, P. Boknik, J. Knapp, B. Linck, H. Luss, J. Neumann, and W. Schmitz
Activation and inactivation of cAMP-response element-mediated gene transcription in cardiac myocytes
Cardiovasc Res, October 1, 2001; 52(1): 95 - 102.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
V.J Owen, P.B.J Burton, A.J Mullen, E.J Birks, P Barton, and M.H Yacoub
Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure
Eur. Heart J., June 2, 2001; 22(12): 1015 - 1020.
[Abstract] [PDF]


Home page
Circ. Res.Home page
M. Iwata, T. Yoshikawa, A. Baba, T. Anzai, I. Nakamura, Y. Wainai, T. Takahashi, and S. Ogawa
Autoimmunity Against the Second Extracellular Loop of {beta}1-Adrenergic Receptors Induces {beta}-Adrenergic Receptor Desensitization and Myocardial Hypertrophy In Vivo
Circ. Res., March 30, 2001; 88(6): 578 - 586.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Marcil and M. B. Anand-Srivastava
Lymphocytes from spontaneously hypertensive rats exhibit enhanced adenylyl cyclase-Gi protein signaling
Cardiovasc Res, January 1, 2001; 49(1): 234 - 243.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Kouchi, O. Zolk, F. Jockenhovel, G. Itter, W. Linz, B. Cremers, and M. Bohm
Increase in Gi{alpha} Protein Accompanies Progression of Post-Infarction Remodeling in Hypertensive Cardiomyopathy
Hypertension, July 1, 2000; 36(1): 42 - 47.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Ribadeau-Dumas, M. Brady, S. Y Boateng, K. Schwartz, and K. R Boheler
Sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) gene products are regulated post-transcriptionally during rat cardiac development
Cardiovasc Res, August 1, 1999; 43(2): 426 - 436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Santalucia, K. R. Boheler, N. J. Brand, U. Sahye, C. Fandos, F. Vinals, J. Ferre, X. Testar, M. Palacin, and A. Zorzano
Factors Involved in GLUT-1 Glucose Transporter Gene Transcription in Cardiac Muscle
J. Biol. Chem., June 18, 1999; 274(25): 17626 - 17634.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Cerbai, R. Pino, M. L Rodriguez, and A. Mugelli
Modulation of the pacemaker current If by {beta}-adrenoceptor subtypes in ventricular myocytes isolated from hypertensive and normotensive rats
Cardiovasc Res, April 1, 1999; 42(1): 121 - 129.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Bohm, S. Ettelbruck, M. Flesch, W. H van Gilst, A. Knorr, C. Maack, Y. M Pinto, M. Paul, A. C.H Teisman, and O. Zolk
{beta}-Adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy
Cardiovasc Res, October 1, 1998; 40(1): 146 - 155.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
F. U. Müller, P. Bokník, J. Knapp, J. Neumann, U. Vahlensieck, E. Oetjen, H. H. Scheld, and W. Schmitz
Identification and expression of a novel isoform of cAMP response element modulator in the human heart
FASEB J, September 1, 1998; 12(12): 1191 - 1199.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
O. Zolk, M. Flesch, G. Nickenig, P. Schnabel, and M. Bohm
Alteration of intracellular Ca2+-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic rats
Cardiovasc Res, July 1, 1998; 39(1): 242 - 256.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Bohm, O. Zolk, M. Flesch, F. Schiffer, P. Schnabel, J.-P. Stasch, and A. Knorr
Effects of Angiotensin II Type 1 Receptor Blockade and Angiotensin-Converting Enzyme Inhibition on Cardiac ß-Adrenergic Signal Transduction
Hypertension, March 1, 1998; 31(3): 747 - 754.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. U Koban, A. F.M Moorman, J. Holtz, M. H Yacoub, and K. R Boheler
Expressional analysis of the cardiac Na-Ca exchanger in rat development and senescence
Cardiovasc Res, February 1, 1998; 37(2): 405 - 423.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Cornelius, S. R. Holmer, F. U. Muller, G. A. J. Riegger, and H. Schunkert
Regulation of the Rat Atrial Natriuretic Peptide Gene After Acute Imposition of Left Ventricular Pressure Overload
Hypertension, December 1, 1997; 30(6): 1348 - 1355.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. Castellano and M. Bohm
The Cardiac ß-Adrenoceptor–Mediated Signaling Pathway and Its Alterations in Hypertensive Heart Disease
Hypertension, March 1, 1997; 29(3): 715 - 722.
[Abstract] [Full Text]


Home page
CirculationHome page
H.-T. Li, N. Y. Honbo, and J. S. Karliner
Chronic Hypoxia Increases ß1-Adrenergic Receptor mRNA and Density but Not Signaling in Neonatal Rat Cardiac Myocytes
Circulation, December 15, 1996; 94(12): 3303 - 3310.
[Abstract] [Full Text]


Home page
CirculationHome page
F. U. Muller, P. Boknik, A. Horst, J. Knapp, B. Linck, W. Schmitz, U. Vahlensieck, M. Bohm, M. C. Deng, and H. H. Scheld
cAMP Response Element Binding Protein Is Expressed and Phosphorylated in the Human Heart
Circulation, October 15, 1995; 92(8): 2041 - 2043.
[Abstract] [Full Text]